Literature DB >> 22341977

Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.

Juchao Ren1, Wenjuan Li, Hainan Liu, Lei Yan, Wei Jiao, Dawei Li, Yueqing Tang, Gangli Gu, Zhonghua Xu.   

Abstract

OBJECTIVES: Reptin is an AAA+ ATPase associated with several complexes involved in chromatin remodeling, transcriptional regulation, DNA damage repair, and telomerase activity. Functional studies have implicated reptin in many cellular processes highly relevant to cancer. In this study, we investigated reptin expression in renal cell carcinoma (RCC) and its biologic functions in RCC cells.
MATERIALS AND METHODS: A total of 81 RCC patients were involved in the study. Cancerous and adjacent normal renal tissues were analyzed for reptin expression using immunohistochemistry. Univariate association with survival was evaluated using Kaplan-Meier curves. Gene expression was depleted with specific small interference RNA. Clonogenesis, cellular senescence, and cell cycle distribution were examined by foci formation, β-galactosidase staining, and flow cytometry, respectively. Cell migration and invasion capability were determined by scratch migration assay and Matrigel invasion assay.
RESULTS: Reptin is overexpressed in cancerous tissues compared with tumor adjacent renal tissues. Cytoplasmic expression of reptin positively correlates with the poor differentiation of RCC, and predicts an unfavorable outcome for patients. Depleting reptin expression substantially inhibited clonogenic potential of cancer cells and induced senescence of RCC cells. Moreover, reptin depletion attenuated migration and invasion ability of RCC cells in vitro.
CONCLUSIONS: Reptin is overexpressed and aberrantly distributed in RCC. It is required for sustained proliferation of cancer cells by preventing cell growth arrest and senescence. Furthermore, reptin promotes cell migration and invasion, which may contribute to the progression of RCC. Therefore, reptin may prove to be a valuable target for prevention and treatment of renal cell carcinoma.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Invasion; Prognosis; RCC; Reptin; Senescence

Mesh:

Substances:

Year:  2012        PMID: 22341977     DOI: 10.1016/j.urolonc.2012.01.004

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  9 in total

1.  AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.

Authors:  Jan-Henrik Mikesch; Wolfgang Hartmann; Linus Angenendt; Otmar Huber; Christoph Schliemann; Maria Francisca Arteaga; Eva Wardelmann; Claudia Rudack; Wolfgang E Berdel; Markus Stenner; Inga Grünewald
Journal:  Cell Oncol (Dordr)       Date:  2018-06-05       Impact factor: 6.730

2.  A Systematic Analysis Reveals the Prognostic and Immunological Role of Reptin/RUVBL2 in Human Tumors.

Authors:  Xiaoru Su; Gaoming Zheng; Zhifang Gui; Xiao Yang; Lahong Zhang; Feng Pan
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

3.  Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.

Authors:  Xiang Zhang; Juchao Ren; Lei Yan; Yueqing Tang; Wenhua Zhang; Dawei Li; Yuanwei Zang; Feng Kong; Zhonghua Xu
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

4.  Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.

Authors:  Anne-Aurélie Raymond; Samira Benhamouche; Véronique Neaud; Julie Di Martino; Joaquim Javary; Jean Rosenbaum
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

5.  Metalloproteinase meprin α regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin.

Authors:  Osman Breig; Maïlyn Yates; Véronique Neaud; Gabrielle Couchy; Aude Grigoletto; Carlo Lucchesi; Johannes Prox; Jessica Zucman-Rossi; Christoph Becker-Pauly; Jean Rosenbaum
Journal:  Oncotarget       Date:  2017-01-31

6.  Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma.

Authors:  Tao Yan; Fang Liu; Jiajia Gao; Haizhen Lu; Jianqiang Cai; Xiaohang Zhao; Yulin Sun
Journal:  Cancer Cell Int       Date:  2019-09-27       Impact factor: 5.722

7.  Abundance of the Fanconi anaemia core complex is regulated by the RuvBL1 and RuvBL2 AAA+ ATPases.

Authors:  Eeson Rajendra; Juan I Garaycoechea; Ketan J Patel; Lori A Passmore
Journal:  Nucleic Acids Res       Date:  2014-11-26       Impact factor: 16.971

Review 8.  The Role of Pontin and Reptin in Cellular Physiology and Cancer Etiology.

Authors:  Yu-Qian Mao; Walid A Houry
Journal:  Front Mol Biosci       Date:  2017-08-24

9.  Sorafenib as an Inhibitor of RUVBL2.

Authors:  Nardin Nano; Francisca Ugwu; Thiago V Seraphim; Tangzhi Li; Gina Azer; Methvin Isaac; Michael Prakesch; Leandro R S Barbosa; Carlos H I Ramos; Alessandro Datti; Walid A Houry
Journal:  Biomolecules       Date:  2020-04-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.